A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 10 strange trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 60% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $68,280 and 8, calls, for a total amount of $323,482.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $165.0 to $580.0 for Eli Lilly over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 805.7 with a total volume of 158.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Eli Lilly's big money trades within a strike price range of $165.0 to $580.0 over the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 09/15/23 | $165.00 | $75.7K | 0 | 0 |
| LLY | CALL | TRADE | BEARISH | 09/15/23 | $500.00 | $67.9K | 2.4K | 0 |
| LLY | CALL | TRADE | BEARISH | 01/17/25 | $570.00 | $37.7K | 35 | 2 |
| LLY | PUT | TRADE | BULLISH | 06/21/24 | $510.00 | $35.8K | 43 | 0 |
| LLY | CALL | TRADE | BULLISH | 09/15/23 | $550.00 | $33.8K | 3.1K | 100 |
Where Is Eli Lilly Standing Right Now?
- With a volume of 387,593, the price of LLY is up 0.68% at $551.74.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 61 days.
What The Experts Say On Eli Lilly:
- JP Morgan has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $600.
- Morgan Stanley has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $617.
- Goldman Sachs has decided to maintain their Neutral rating on Eli Lilly, which currently sits at a price target of $470.
- BMO Capital has decided to maintain their Outperform rating on Eli Lilly, which currently sits at a price target of $633.
- Cantor Fitzgerald downgraded its action to Overweight with a price target of $550
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
